Aerin Medical is a privately held, venture-backed company with offices in Sunnyvale, California and Austin, Texas. Aerin’s mission is to provide ENT physicians with non-invasive procedures for the treatment of chronic nasal airway conditions. The company’s FDA-cleared products, the VivAer Stylus for nasal airway obstruction and the RhinAer Stylus for chronic rhinitis, leverage Aerin’s proprietary temperature-controlled technology, which allows ENT physicians to reliably improve patients’ symptoms with a nonsurgical procedure under local anesthetic in their office.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/22/16 | $16,700,000 | Series C |
KCK Group Targeted Technology Fund | undisclosed |
| 08/17/20 | $48,000,000 |
KCK Group OrbiMed Advisors Questa Capital  | undisclosed |
